Sponsorship Statement: This continuing medical education activity is sponsored by 
with 
as an educational partner
Title: Comprehensive Review of the Management of Hypertension
Overview: Hypertension has been estimated to affect more than 43 million people in the United States, almost 25% of the adult population, significantly increasing their risk of stroke, heart attack and renal failure. In this program, leading specialists will present the latest science and review current guidelines on the diagnosis and treatment of hypertension.
Target Audience: This educational activity is designed for cardiologists, endocrinologists, internal medicine, and primary care physicians.
Learning Objectives:
At the conclusion of this activity participants should be able to:
- Develop an appropriate profiling and monitoring plan for patients with hypertension.
- Evaluate the current evidence concerning critical hypertension management issues, specifically left ventricular regression and hyperkalemia and RAAS blockade.
- Implement evidence-based strategies for hypertension management in patients with diabetes.
Faculty:
All People with CKD Should Have a Blood Pressure Lower Than 130/80 mm Hg (Con)
Rajiv Agarwal, MD
Professor of Medicine
Division of Nephrology
Indiana University
Indianapolis, IN
Introduction
Prevention of Diabetic Nephropathy: The Critical Role of BP Control
ASH 2010 Updates
George L. Bakris, MD
Professor of Medicine
Director, Hypertensive Diseases Unit
University of Chicago Pritzker School of Medicine
Chicago, IL
Management of Resistant Hypertension
David A. Calhoun, MD
Professor of Medicine
Vascular Biology and Hypertension Program
The University of Alabama at Birmingham
Birmingham, AL
Profiling the Hypertensive Patient: What is Mandatory and What is Optional?
Matthew J. Sorrentino, MD
Professor of Medicine
Section of Cardiology
University of Chicago Pritzker School of Medicine
Chicago, IL
Hyperkalemia Management and RAAS Blockade in the High-Risk Diabetes Patient: How Can We Ensure Optimal BP Control?
All People with CKD Should Have a Blood Pressure Lower Than 130/80 mm Hg (Pro)
Robert D. Toto, MD
Professor of Medicine
Director, Clinical Nephrology and Patient-Oriented Research
Department of Medicine
Division of Nephrology
University of Texas SW Medical Center
Dallas, TX
Continuing Medical Education Information:
University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
University of Chicago Pritzker School of Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, March 4, 2011 to March 2, 2012.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, watch and listen to the lectures, complete the CME Post-test, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the Post-test questions correctly. Upon receipt of the completed materials, if a satisfactory score on the Post test is achieved, University of Chicago will issue an AMA PRA Category 1 Credit(s) TM certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
The authors disclose that they do have relevant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
George L. Bakris, MD, FAHA, FASN
Consulting Fees: Abbott, CVRx, Daichi-Sankyo, Forest, GSK, Merck, Novartis, Takeda, Walgreens
Fees for Non-CME Services: Forest, Novartis
Rajiv Agarwal, MD
Consulting Fee’s: Abbott, Amgen, Merck, Rockwell Med., Watson
Fee’s for Non-CME Services: Abbott, Merck, Watson
David A. Calhoun, MD
Consulting Fees: CVRx, Novartis
Matthew J. Sorrentino, MD, FACC
Fee’s for Non-CME Services: Merck & Co., Inc, Novartis, Pfizer
Robert D. Toto, MD
Consulting Fee’s: Takeda
Contracted Research: Amgen, Novartis, Reata
University of Chicago and Vindico staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at University of Chicago and Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by University of Chicago Pritzker School of Medicine and Vindico Medical Education®, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright© 2010 University of Chicago Pritzker School of Medicine and Vindico Medical Education®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of University of Chicago Pritzker School of Medicine and Vindico Medical Education® continuing medical education activities does not necessarily reflect the views and opinions of University of Chicago Pritzker School of Medicine or Vindico Medical Education®. Neither University of Chicago Pritzker School of Medicine, Vindico Medical Education® nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Questions? Contact us at:
Center for Continuing Medical Education
Division of the Biological Sciences and the Pritzker School of Medicine
The University of Chicago
950 E. 61st Street, Suite 101
Chicago, IL 60637
Phone: 773/702-1056
Fax: 773/702-1736
Email: cme@bsd.uchicago.edu